» Articles » PMID: 38133726

SARS-CoV-2 Variants Are Associated with Different Clinical Courses in Children with MIS-C

Overview
Journal World J Pediatr
Specialty Pediatrics
Date 2023 Dec 22
PMID 38133726
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent infection with SARS‑CoV‑2 in children has been associated with multisystem inflammatory syndrome in children (MIS-C). SARS‑CoV‑2 has undergone different mutations. Few publications exist about specific variants and their correlation with the severity of MIS-C.

Methods: This was a single-center, retrospective study including all patients admitted with MIS-C at Rady Children's Hospital-San Diego between May 2020 and March 2022. Local epidemiologic data, including viral genomic information, were obtained from public records. Demographics, clinical presentation, laboratory values, and outcomes were obtained from electronic medical records.

Results: The analysis included 104 pediatric patients. Four MIS-C waves were identified. Circulating variants in San Diego during the first wave included clades 20A to C. During the second wave, there were variants from clades 20A to C, 20G, 21C (Epsilon), 20I (Alpha), and 20J (Gamma). The third wave had Delta strains (clades 21A, 21I, and 21J), and the fourth had Omicron variants (clades 21K, 21L, and 22C). MIS-C presented with similar symptoms and laboratory findings across all waves. More patients were admitted to the pediatric intensive care unit (PICU) (74%) and required inotropic support (63%) during the second wave. None of the patients required mechanical circulatory support, and only two required invasive ventilatory support. There was no mortality.

Conclusions: The various strains of SARS-CoV-2 triggered MIS-C with differing severities, with the second wave having a more severe clinical course. Whether the differences in disease severity across variants were due to changes in the virus or other factors remains unknown.

Citing Articles

Characteristics of Multisystem Inflammatory Syndrome in Children Across COVID-19 Variants in Vojvodina.

Vijatov-duric G, Milanovic B, Barisic N, Ivetic J, duretic A, Kesic J J Clin Med. 2024; 13(22).

PMID: 39597816 PMC: 11594632. DOI: 10.3390/jcm13226672.

References
1.
Harahsheh A, Sharron M, Bost J, Ansusinha E, Wessel D, DeBiasi R . Comparison of First and Second Wave Cohorts of Multisystem Inflammatory Disease Syndrome IN Children. Pediatr Infect Dis J. 2021; 41(1):e21-e25. PMC: 8658056. DOI: 10.1097/INF.0000000000003388. View

2.
Gangavarapu K, Latif A, Mullen J, Alkuzweny M, Hufbauer E, Tsueng G . Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat Methods. 2023; 20(4):512-522. PMC: 10399614. DOI: 10.1038/s41592-023-01769-3. View

3.
Whittaker R, Greve-Isdahl M, Boas H, Suren P, Buanes E, Veneti L . COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway. Pediatrics. 2022; 150(3). DOI: 10.1542/peds.2022-057564. View

4.
Pino R, Antonanzas J, Paredes-Carmona F, Perramon A, Riviere J, Coma M . Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain. Eur J Pediatr. 2023; 182(4):1897-1909. PMC: 9937862. DOI: 10.1007/s00431-023-04862-z. View

5.
Miller A, Zambrano L, Yousaf A, Abrams J, Meng L, Wu M . Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021. Clin Infect Dis. 2021; 75(1):e1165-e1175. PMC: 8689703. DOI: 10.1093/cid/ciab1007. View